A Whole‐Course‐Repair System Based on Stimulus‐Responsive Multifunctional Hydrogels for Myocardial Tissue Regeneration
Small Methods · 2024-12 · 8 (12)
DOI: 10.1002/smtd.202400121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small Methods, online erschienen am 25.06.2024. Verfasst von Wenqi Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: National Engineering Research Center for Biomaterials, College of Biomedical Engineering, Chuanda-Jinbo Joint Research Center, Med-X Center for Mater…. Hauptthemen laut MEDLINE: Hydrogels, Myocardial Infarction, Curcumin, Regeneration. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Natural Science Foundation of Sichuan Province.
Abstract (Originalsprache)
Myocardial infarction (MI) has emerged as the predominant cause of cardiovascular morbidity globally. The pathogenesis of MI unfolds as a progressive process encompassing three pivotal phases: inflammation, proliferation, and remodeling. Smart stimulus‐responsive hydrogels have garnered considerable attention for their capacity to deliver therapeutic drugs precisely and controllably at the MI site. Here, a smart stimulus‐responsive hydrogel with a dual‐crosslinked network structure is designed, which enables the precise and controlled release of therapeutic drugs in different pathological stages for the treatment of MI. The hydrogel can rapidly release curcumin (Cur) in the inflammatory phase of MI to exert anti‐apoptotic/anti‐inflammatory effects. Recombinant humanized collagen type III (rhCol III) is loaded in the hydrogel and released as the hydrogel swelled/degraded during the proliferative phase to promote neovascularization. RepSox (a selective TGF‐β inhibitor) releases from Pluronic F‐127 grafted with aldehyde nanoparticles (PF127‐CHO@RepSox NPs) in the remodeling phase to against fibrosis. The results in vitro and in vivo suggest that the hydrogel improves cardiac function and alleviates cardiac remodeling by suppressing inflammation and apoptosis, promoting neovascularization, and inhibiting myocardial fibrosis. A whole‐course‐repair system, leveraging stimulus‐responsive multifunctional hydrogels, demonstrates notable effectiveness in enhancing post‐MI cardiac function and facilitating the restoration of damaged myocardial tissue.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Engineering Research Center for Biomaterials, College of Biomedical Engineering, Chuanda-Jinbo Joint Research Center, Med-X Center for Materials, Sichuan University, Chengdu, 610064, P. R. China.
- Department of Cardiology, General Hospital of Northern Theater Command Shenyang, Shenyang, 110016, China.
ORCID-Profile: Yunbing Wang
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Natural Science Foundation of Sichuan Province
- Science and Technology Major Project
- Fundamental Research Funds for the Central Universities
- Med-X Innovation Programme of Med-X Center of Materials, Sichuan University
Zitieren
APA
Liu, W., Long, L., Wang, Z., He, S., Han, Y., Yang, L., Hu, C., & Wang, Y. (2024). A Whole‐Course‐Repair System Based on Stimulus‐Responsive Multifunctional Hydrogels for Myocardial Tissue Regeneration. Small Methods, 8(12). https://doi.org/10.1002/smtd.202400121
Vancouver
Liu W, Long L, Wang Z, He S, Han Y, Yang L, et al. A Whole‐Course‐Repair System Based on Stimulus‐Responsive Multifunctional Hydrogels for Myocardial Tissue Regeneration. Small Methods. 2024;8(12). doi:10.1002/smtd.202400121
BibTeX
@article{Liu2024,
author = {Liu, Wenqi and Long, Linyu and Wang, Zhicun and He, Shuyi and Han, Yaling and Yang, Li and Hu, Cheng and Wang, Yunbing},
title = {A Whole‐Course‐Repair System Based on Stimulus‐Responsive Multifunctional Hydrogels for Myocardial Tissue Regeneration},
journal = {Small Methods},
year = {2024},
volume = {8},
number = {12},
doi = {10.1002/smtd.202400121}
}
EUVIMED